Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Unknown 3Completed 1

Sponsor Class

OTHER_GOV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Hypertension, Portal 3Carcinoma, Hepatocellular 3Hemangioma, Capillary 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Liver Cirrhosis 1Hemangiosarcoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Propranolol × Clear all
NCT01451658 2019-09-04

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01970748 2019-08-30

P-HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal

NCT01298284 2011-06-15

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡